Cerebrovascular Accident: Clinical Trials

19 trials for Cerebrovascular Accident, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 2 unknown, 2 withdrawn, 1 terminated. 19 Phase 1, 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 119Completed 14, Unknown 2, Withdrawn 2, Terminated 1
Phase 26Completed 4, Terminated 1, Unknown 1

Follow Cerebrovascular Accident: new trials by email Literature Review of Cerebrovascular Accident trials Research Report on Cerebrovascular Accident

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Trunk Exercise on Trunk Control and Balance in Persons With Stroke
trunk exercise on unstable exercise, Upper limb range of motion exercise - Cerebrovascular Accident, Balance Impairment
Phase 1 / Phase 2CompletedNational Cheng Kung University352018-08-092020-06-16
Post-Stroke Improvement of Motor Function
Perfusion with New Combination Medication - Cerebrovascular Accident
Phase 1CompletedFundatia Bio-Forum172017-08-082018-11-19
AMES Treatment of the Proximal Arm in Chronic Stroke
30 PAAD treatments - Stroke, Cerebrovascular Accident
Phase 1WithdrawnOregon Health and Science University2013-08-012019-03-29
AMES Treatment of the Impaired Leg in Chronic Stroke Patients
AMES- Leg treatment - Stroke, Cerebrovascular Accident
Phase 1 / Phase 2UnknownAMES Technology222011-01-012016-12-08
AMES + Brain Stimulation
AMES + brain stimulation - Stroke, Cerebrovascular Accident
Phase 1UnknownAMES Technology62010-07-012016-12-08
Optimizing Hand Rehabilitation Post-Stroke Using Interactive Virtual Environments
HAS Training, HAT training, Bimanual Training - Cerebrovascular Accident, Hemiparesis
Phase 1CompletedNew Jersey Institute of Technology552009-03-012015-10-07
Safety and Efficacy of Autologous Stem Cell Therapy in Chronic Stroke
Autologous bone marrow mononuclear cell transplantation - Cerebrovascular Accident
Phase 1WithdrawnNeurogen Brain and Spine Institute2008-12-012018-10-25
Outcomes Associated With Progressive Balance And Gait Training Using The KineAssist® Robot
Balance Task Training with therapist guarding support, Balance task training with robotic guarding support, Challneged balance task training with robotic guarding support - Cerebrovascular Accident
Phase 1CompletedUniversity of Alabama at Birmingham362008-10-012017-01-19
Clinic-Based AMES Treatment of Stroke
Assisted movement and enhanced sensation - Stroke, Cerebrovascular Accident
Phase 1 / Phase 2TerminatedOregon Health and Science University32008-04-012017-01-23
Anti-MAG First Administration to Human
GSK249320A, Placebo - Cerebrovascular Accident
Phase 1CompletedGlaxoSmithKline462007-08-012017-07-21
Treating Intention In Aphasia: Neuroplastic Substrates
Word-finding with intention component, Word-finding with no intention component - Aphasia, Cerebrovascular Accident
Phase 1 / Phase 2CompletedUniversity of Florida142007-03-012012-05-03
Safety and Efficacy of NeuroFlo in 8-24 Hour Stroke Patients
NeuroFloâ„¢ Catheter - Cerebrovascular Accident
Phase 1CompletedCoAxia262007-02-012009-02-05
Driving Neuroplasticity With Nerve Stimulation and Modified CIT
peripheral nerve stimulation - Stroke, Cerebrovascular Accident
Phase 1 / Phase 2CompletedUniversity of Kentucky212006-11-012023-09-13
Robot-Assisted Motivating Rehabilitation
TheraDrive Assistive Device, Rote Therapy versus Fun Therapy - Stroke, Cerebrovascular Accident
Phase 1CompletedMedical College of Wisconsin242006-07-012014-02-04
Safety Study of Interferon Beta 1a to for Acute Stroke
Interferon beta-1a - Cerebrovascular Accident
Phase 1CompletedNational Institute of Neurological Disorders and Stroke (NINDS)602004-11-172017-07-02
Improvement of Use Dependent Plasticity in Chronic Stroke Patients
Electrocardiogram - Healthy, Cerebrovascular Accident
Phase 1CompletedNational Institute of Neurological Disorders and Stroke (NINDS)482003-11-062017-07-02
Preliminary Study of Transcranial Magnetic Stimulation for Stroke Rehabilitation
rTMS, Magstim - Cerebrovascular Accident
Phase 1CompletedNational Institute of Neurological Disorders and Stroke (NINDS)152002-11-182017-07-02
Safety Study of a Recombinant Human Plasminogen Activator to Treat Acute Ischemic Stroke.
Recombinant Human Plasminogen Activator (HTUPA) - Cerebrovascular Accident
Phase 1 / Phase 2CompletedGlobal Biotech302001-04-012007-01-04
Potential Risk Factors for Stroke
cytokine and leukocyte activation profile - Carotid Atherosclerosis, Cerebrovascular Accident
Phase 1CompletedNational Institute of Neurological Disorders and Stroke (NINDS)5001993-10-012008-03-04

Narrower conditions

Stroke (19)  ·  Ischemia (2)  ·  Paresis (2)  ·  Aphasia (1)  ·  Ataxia (1)  ·  Atherosclerosis (1)  ·  Brain Ischemia (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Carotid Artery Diseases (1)  ·  Carotid Stenosis (1)  ·  Diabetes Mellitus (1)  ·  Hemiplegia (1)  ·  Hypercholesterolemia (1)  ·  Hypertension (1)  ·  Inflammation (1)

Broader conditions

Brain Diseases (19)  ·  Cardiovascular Diseases (19)  ·  Central Nervous System Diseases (19)  ·  Cerebrovascular Disorders (19)  ·  Nervous System Diseases (19)  ·  Vascular Diseases (19)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Neurologic Manifestations (5)  ·  Signs and Symptoms (5)  ·  Behavior (2)  ·  Pathologic Processes (2)  ·  Arterial Occlusive Diseases (1)  ·  Arteriosclerosis (1)  ·  Bronchial Diseases (1)  ·  Bronchiolitis (1)

Interventions

Cytokines (1)  ·  Interferon beta-1a (1)  ·  Perfusion (1)  ·  Transcranial Magnetic Stimulation (1)

Sponsors

National Institute of Neurological Disorders and Stroke (NINDS) (4)  ·  AMES Technology (2)  ·  Oregon Health and Science University (2)  ·  CoAxia (1)  ·  Fundatia Bio-Forum (1)  ·  GlaxoSmithKline (1)  ·  Global Biotech (1)  ·  Medical College of Wisconsin (1)  ·  National Cheng Kung University (1)  ·  Neurogen Brain and Spine Institute (1)  ·  New Jersey Institute of Technology (1)  ·  University of Alabama at Birmingham (1)  ·  University of Florida (1)  ·  University of Kentucky (1)

Countries

United States (14)  ·  Taiwan (2)  ·  Australia (1)  ·  Canada (1)  ·  Germany (1)  ·  India (1)  ·  Romania (1)  ·  Switzerland (1)

Top investigators

Barry Oken, MD (3)  ·  Alok K Sharma, M.S., M.Ch (1)  ·  Bruce Crosson, PhD (1)  ·  Elliot Roth, MD (1)  ·  Felician Stancioiu (1)  ·  Han-Hwa Hu, M.D. (1)  ·  Michelle J Johnson, PhD (1)  ·  Paul J Cordo, Ph.D (1)  ·  Paul J. Cordo, PHD (1)  ·  Paul J. Cordo, PhD (1)  ·  Sergei V. Adamovich, PhD (1)

Results publications

PMID 16424373, PMID 19615045, PMID 19666345, PMID 19965145, PMID 21575185, PMID 22254998, PMID 22264202, PMID 22275632, PMID 23267856, PMID 23366834, PMID 23366943, PMID 25126443, PMID 25148846, PMID 25570772, PMID 26084322, PMID 26945226, PMID 33175411

NIH funding

R01DC007387 (1), R43NS067694 (1), R44NS060192 (1)